|
Volumn 19, Issue 12, 2000, Pages 1211-1213
|
Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes
|
Author keywords
Aerosol route; Measles antibody; Persistence; Revaccination
|
Indexed keywords
ANTIBODY;
MEASLES VACCINE;
ADOLESCENT;
ANTIBODY RESPONSE;
ANTIBODY TITER;
ARTICLE;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
MAJOR CLINICAL STUDY;
MEASLES;
MEXICO;
NEBULIZER;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VACCINATION;
ADMINISTRATION, INHALATION;
ADOLESCENT;
ANTIBODIES, VIRAL;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HUMANS;
IMMUNIZATION, SECONDARY;
INJECTIONS, SUBCUTANEOUS;
MALE;
MEASLES;
MEASLES VACCINE;
MEASLES VIRUS;
TIME FACTORS;
|
EID: 0034537371
PISSN: 08913668
EISSN: None
Source Type: Journal
DOI: 10.1097/00006454-200012000-00021 Document Type: Article |
Times cited : (37)
|
References (13)
|